Novartis India
BSE: 500672 | NSE: NOVARTIND | ISIN: INE234A01025 | Pharmaceuticals
- Directors Report
- Chairman's Speech
- Auditors Report
- Notes To Accounts
- Accounting Policy
- Finished Products
- Raw Materials
| Notes to Accounts | Year End : Mar '09 |
1. Estimated amount of contracts remaining to be executed on capital
account and not provided for (net of advances) Rs 943(000) [Previous
year Rs 1,309(000)].
As at As at
31st March 2009 31st March 2008
Rs 000 Rs 000
2. Contingent Liabilities
(a) Claims against the company not
acknowledged as debts
Income tax matters
(i) Matters decided in favour of the
company but disputed further by the
income tax authorities 303,699 303,699
(ii) Matters decided against the company
in respect of which the company has
preferred an appeal 119,618 123,410
Sales tax matters 166,097 737,885
Service tax matter - 165
Excise matters 5,110 5,777
Claims from a third party
manufacturer in respect of
Excise matter 667 26,308
Claim for penalty under the
Foreign
Exchange Management Act, 1999 - 7,300
Claims from Consumers 1,758 2,058
Others 2,100 3,910
(b) Uncalled liability on partly
paid share in Hill
Properties Limited 2 2
Notes :
(i) Future cash outflows in respect of (a) above are determinable only
on receipt of judgements/ decisions pending with various
authorities/forums and/or final outcome of the matters.
(ii) Future cash outflow in respect of (b) above is dependent on the
call to be made by Hill Properties Limited.
3. (a) Salaries, Wages and Bonus include Rs 5,253(000) [Previous year
Rs 2,607(000)] paid to employees under the Voluntary Retirement
Schemes.
(b) Voluntary Retirement Costs represent the actuarial value as at 31st
March 2009 of compensation payable under the Voluntary Retirement
Schemes. Amount payable within one year approximately Rs 3,956(000)
[Previous year Rs 5,054(000)].
4. Previous year figures have been regrouped where necessary. |
|
![]() | |
| Source : Religare Technova | |
![]() | |




Online










